Namocare to Turn India Into the Largest Pharma Manufacturer in the World

'Namocare' Indian central government’s national health insurance scheme may make India the largest drug maker in the world, says Union Chemicals and Fertilisers Minister, Ananth Kumar.

Inaugurating the third edition of the 'India Pharma 2018 and India Medical Device 2018, International conference and exhibition' here, Ananth Kumar said a new pharmaceuticals policy in the offing would ensure effective implementation of 'Namocare', which has the potential to turn India into the largest pharma manufacturer of the world in the next three years.

Obamacare Increases Health Insurance Rates in US
An estimated 20 million previously uninsured U.S. citizens have gained access to health insurance after Obamacare since 2010.

‘'Namocare' will pave the way for major reforms in the drug price control order and double the market size of the $65 billion Indian pharma and $12 billion medical devices industry over the next five years.’

Tweet it Now

"The new policy will pave the way for major reforms in the drug price control order and double the market size of the $65 billion Indian pharma and $12 billion medical devices industry over the next five years," he said.

As the world's largest state-funded programme, the National Health Protection Scheme will provide Rs 5 lakh medical insurance cover to 10 crore families covering about 50 crore people across the country. Rs 2,000 crore has been allocated in the Union Budget 2018-19 for it.

Calling upon the healthcare industry to support the government in implementing the ambitious scheme, which would have a framework for universal health coverage to provide affordable and quality healthcare for the poor, he said as Namocare will roll out over the next three months, the pharma sector and the medical devices industry should expand their capacity to make affordable drugs and devices of global standards to meet the scheme's needs.

Obamacare Benefitted Latinos, but Persistent Disparities Remain
Persistent disparities in access to and utilization of health care were found between non-citizens, naturalized citizens and U.S.-born citizens.

Admitting that the mega scheme cannot be implemented in the prevailing fragmented ecosystem of the pharma industry, the Minister said the new pharma policy would unify and synergize healthcare sector's components, including the drug price control order, manufacturing, research and development, financing, quality control, and so on.

"The pharma and medical devices industry has to take up the Namocare challenge in coordination with the 'Make in India' initiative to ensure health security for all," he said, adding he had given the stakeholders a 3A formula - 'availability, authenticity, and affordability without compromising on quality.'

Obamacare Repeal Under Threat
House Speaker Paul Ryan said Republicans will move to strip all federal funding for Planned Parenthood as part of the process to dismantle Obamacare.

The minister also discussed with the executives of the pharma and medical devices industry the problems and challenges faced by the sector and exhorted them to find solutions for providing affordable and quality healthcare for all across the country.

Organised by the Department of Pharmaceuticals (DoP) in the Ministry of Chemicals and Fertilizers and the Federation of Indian Chambers of Commerce and Industry (Ficci), the three-day mega event with "Affordable and Quality Healthcare for All in the country' as the theme is being held at the Bengaluru International Exhibition Centre.

US Health Insurer UnitedHealth Group to Mostly Exit Obamacare
UnitedHealth Group said that it would pull back from participation in the Obama administration's signature health care reforms because it lost money on the program.

About 500 delegates from across the country and overseas are participating in the event, while 300 firms and 50 start-ups are showcasing their products and technologies there.

Source-IANS